Evidence map›Paper›PMID 29197599›Full record

ArticleThe Journal of infection2018

Meningococcal carriage within households in the African meningitis belt: A longitudinal pilot study.

Nicole E Basta, Abdoulaye Berthe, Mahamadou Keita, Uma Onwuchekwa, Boubou Tamboura, Awa Traore, Musa Hassan-King, Olivier Manigart, Maria Nascimento, James M Stuart and 11 more

Abstract read
In one paragraph

Article in The Journal of infection, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Prevalence and persistence ofEpidemiology and infection · 2023
    Article
  3. Article
  4. Evaluation of pharyngeal carriage ofNew microbes and new infections · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Nicole E BastaDivision of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota 55454, USA. Electronic address: nebasta@umn.edu.
Abdoulaye BertheCentre pour les Vaccins en Developpement-Mali, Centre National d'Appui a la lutte contre la Maladie (CNAM) Ministère de la Santé, Ex-Institut Marchoux, BP 251, Bamako, Mali.
Mahamadou KeitaCentre pour les Vaccins en Developpement-Mali, Centre National d'Appui a la lutte contre la Maladie (CNAM) Ministère de la Santé, Ex-Institut Marchoux, BP 251, Bamako, Mali.
Uma OnwuchekwaCentre pour les Vaccins en Developpement-Mali, Centre National d'Appui a la lutte contre la Maladie (CNAM) Ministère de la Santé, Ex-Institut Marchoux, BP 251, Bamako, Mali.
Boubou TambouraCentre pour les Vaccins en Developpement-Mali, Centre National d'Appui a la lutte contre la Maladie (CNAM) Ministère de la Santé, Ex-Institut Marchoux, BP 251, Bamako, Mali.
Awa TraoreCentre pour les Vaccins en Developpement-Mali, Centre National d'Appui a la lutte contre la Maladie (CNAM) Ministère de la Santé, Ex-Institut Marchoux, BP 251, Bamako, Mali.
Musa Hassan-KingLondon School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, United Kingdom.
Olivier ManigartCentre pour les Vaccins en Developpement-Mali, Centre National d'Appui a la lutte contre la Maladie (CNAM) Ministère de la Santé, Ex-Institut Marchoux, BP 251, Bamako, Mali; London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, United Kingdom.
Maria NascimentoLondon School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, United Kingdom.
James M StuartLondon School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, United Kingdom.
Caroline TrotterDepartment of Veterinary Medicine, University of Cambridge, Cambridge, CB3 0ES, United Kingdom.
Jayne BlakeMeningococcal Reference Unit, Public Health England, Manchester Royal Infirmary, Manchester, M13 9WL, United Kingdom.
Anthony D CarrMeningococcal Reference Unit, Public Health England, Manchester Royal Infirmary, Manchester, M13 9WL, United Kingdom.
Stephen J GrayMeningococcal Reference Unit, Public Health England, Manchester Royal Infirmary, Manchester, M13 9WL, United Kingdom.
Lynne S NewboldMeningococcal Reference Unit, Public Health England, Manchester Royal Infirmary, Manchester, M13 9WL, United Kingdom.
Yangqing DengDivision of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota 55454, USA.
Julian WolfsonDivision of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota 55454, USA.
M Elizabeth HalloranVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA; Department of Biostatistics, University of Washington, Seattle, Washington 98195, USA.
Brian GreenwoodLondon School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, United Kingdom.
Ray BorrowMeningococcal Reference Unit, Public Health England, Manchester Royal Infirmary, Manchester, M13 9WL, United Kingdom.
Samba O SowCentre pour les Vaccins en Developpement-Mali, Centre National d'Appui a la lutte contre la Maladie (CNAM) Ministère de la Santé, Ex-Institut Marchoux, BP 251, Bamako, Mali.

Funding

Antibody persistence after conjugate meningococcal group A vaccination in MaliDP5OD009162 · OD · UNIVERSITY OF WASHINGTON · PI BASTA, NICOLE ELAINE · 2011 to 2015
$1.9M
Acquisition and loss of Neisseria meningitidis carriage in households in MaliR03AI092121 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HALLORAN, M ELIZABETH · 2011 to 2012
$168k
NIAID NIH HHS R03 AI092121NIH HHS DP5 OD009162Wellcome Trust 086546
6 · The paper itself

Abstract

objectivesCarriers of Neisseria meningitidis are a key source of transmission. In the African meningitis belt, where risk of meningococcal disease is highest, a greater understanding of meningococcal carriage dynamics is needed.

methodsWe randomly selected an age-stratified sample of 400 residents from 116 households in Bamako, Mali, and collected pharyngeal swabs in May 2010. A month later, we enrolled all 202 residents of 20 of these households (6 with known carriers) and collected swabs monthly for 6 months prior to MenAfriVac vaccine introduction and returned 10 months later to collect swabs monthly for 3 months. We used standard bacteriological methods to identify N. meningitidis carriers and fit hidden Markov models to assess acquisition and clearance overall and by sex and age.

resultsDuring the cross-sectional study 5.0% of individuals (20/400) were carriers. During the longitudinal study, 73 carriage events were identified from 1422 swabs analyzed, and 16.3% of individuals (33/202) were identified as carriers at least once. The majority of isolates were non-groupable; no serogroup A carriers were identified.

conclusionsOur results suggest that the duration of carriage with any N. meningitidis averages 2.9 months and that males and children acquire and lose carriage more frequently in an urban setting in Mali. Our study informed the design of a larger study implemented in seven countries of the African meningitis belt.

Indexed as

AdolescentAdultCarrier StateChildChild, PreschoolCross-Sectional StudiesFamily CharacteristicsFemaleHumansInfantLongitudinal StudiesMaleMaliMass ScreeningMeningitis, MeningococcalMeningococcal InfectionsAfricaBacterial MeningitisCarriersEpidemiologyMaliMeningococcal diseaseNeisseria meningitidis

Identifiers

PMID29197599
PMCPMC5790055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.